Medical Device – The Healthcare News.com

Medtronic’s OsteoCool™ Procedure Shows Significant, Swift Pain Relief and Sustained Improvement for Cancer Patients

Medtronic plc (NYSE: MDT) today announced the release of outcomes in the first 100 patients treated with the OsteoCool™ Radiofrequency Ablation (RFA) System in the OPuS One Clinical Study (as … Read More

Flash News

Former Sales Representative Indicted in Compounded Prescription Drug Scheme

Sidra Medicine Appoints Dr. Barbro Fridén as Chief Executive Officer

Oklahoma Health Care Authority Chooses UnitedHealthcare to Serve its Medicaid Beneficiaries

Quotient Sciences Acquires Arcinova, the UK-Based Contract Development and Manufacturing Organization

Cytiva acquires Vanrx Pharmasystems, Canadian aseptic filling innovator

Scapa Healthcare Enhances Manufacturing and Innovation Capabilities at its Knoxville, TN Center of Excellence

Medtronic’s OsteoCool™ Procedure Shows Significant, Swift Pain Relief and Sustained Improvement for Cancer Patients

Category: Medical Device

Medtronic’s OsteoCool™ Procedure Shows Significant, Swift Pain Relief and Sustained Improvement for Cancer Patients